Back to search
FDAFDA · Food and drugs·Recall number Z-0797-2023

VIDAS CLINICAL VIDAS RUB IGG 60 TESTS, CATALOG 30226

Published January 11, 2023 · Recall initiated: November 9, 2022

Summary

FDA records medical device Class II recall Z-0797-2023, published January 11, 2023 and initiated November 9, 2022. Recalling firm: Biomerieux Inc; Status: Ongoing; Reported quantity: 2 units; Lot: UDI/DI 03573026138585, Batch Numbers: 1009370850. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

As the temperature and time out of range was exceeded, product performances cannot be guaranteed

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Biomerieux Inc
Distributor
US Nationwide distribution.
Lot
UDI/DI 03573026138585, Batch Numbers: 1009370850
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was VIDAS CLINICAL VIDAS RUB IGG 60 TESTS, CATALOG 30226 recalled?

Yes. FDA published recall Z-0797-2023 on January 11, 2023. Reported hazard: As the temperature and time out of range was exceeded, product performances cannot be guaranteed

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail